ArticleFrontiers in immunology2023

What makes TMB an ambivalent biomarker for immunotherapy? A subtle mismatch between the sample-based design of variant callers and real clinical cohort.

Yuqian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.